The Securities Commission granted Tryp Therapeutics Inc.’s application to cease being a reporting issuer in all Canadian jurisdictions. The decision was based on the following key facts: the company’s securities are owned by fewer than 15 securityholders in each Canadian jurisdiction and fewer than 51 worldwide, none of its securities are traded on any marketplace, and the company is not in default of securities legislation. The relevant laws underpinning this decision include section 88 of the Securities Act, R.S.B.C. 1996, c. 418, and section 1(10)(a)(ii) of the Securities Act, R.S.O. 1990, c. S.5. The order was issued by the British Columbia Securities Commission, with reliance on Multilateral Instrument 11-102 Passport System and National Policy 11-206 Process for Cease to be a Reporting Issuer Applications.
